Company news

Adaptive Biotechnologies Corporation news in 2024

Adaptive Biotechnologies Corporation's news releases, calls and decks from 2024, newest first.

View company

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

December 6, 2024

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

December 2, 2024

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

November 6, 2024

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma

November 6, 2024

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024

October 8, 2024

Adaptive Announces IVDR Certification for clonoSEQ® in European Union

August 28, 2024

Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

August 21, 2024

Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results

July 31, 2024

Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

July 10, 2024

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

May 30, 2024

Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024

Adaptive Biotechnologies Reports First Quarter 2024 Financial Results

May 6, 2024

Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024

April 16, 2024

Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue

April 1, 2024

Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024

March 26, 2024

Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference

February 21, 2024

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results

February 13, 2024

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024

January 28, 2024

Calls in 2024

Decks in 2024